Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 4
1988 7
1989 5
1990 5
1991 3
1992 1
1994 6
1995 3
1996 3
1997 7
1998 7
1999 11
2000 9
2001 13
2002 17
2003 13
2004 2
2005 5
2006 4
2007 6
2009 1
2010 2
2011 1
2012 3
2013 2
2014 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Results by year
Filters applied: . Clear all
Page 1
Olanzapine. Pharmacokinetic and pharmacodynamic profile.
Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Callaghan JT, et al. Clin Pharmacokinet. 1999 Sep;37(3):177-93. doi: 10.2165/00003088-199937030-00001. Clin Pharmacokinet. 1999. PMID: 10511917 Review.
Olanzapine: an atypical antipsychotic for schizophrenia.
Lund BC, Perry PJ. Lund BC, et al. Expert Opin Pharmacother. 2000 Jan;1(2):305-23. doi: 10.1517/14656566.1.2.305. Expert Opin Pharmacother. 2000. PMID: 11249551 Review.
Muscarinic receptor differentiation.
Mitchelson F. Mitchelson F. Pharmacol Ther. 1988;37(3):357-423. doi: 10.1016/0163-7258(88)90005-8. Pharmacol Ther. 1988. PMID: 3290911 Review. No abstract available.
The relationship of pharmacology to side effects.
Casey DE. Casey DE. J Clin Psychiatry. 1997;58 Suppl 10:55-62. J Clin Psychiatry. 1997. PMID: 9265918 Free article. Review.
137 results
Jump to page
Feedback